Tilde Sciences
Jersey City, United States (US) · Health and Medical
Do your work at Tilde Sciences?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
Tilde Sciences is a US-based pharmaceutical company specializing in the development and commercialization of specialty pharmaceuticals for rare diseases. We are dedicated to addressing the unique challenges associated with orphan conditions, offering targeted therapies to improve patient outcomes. Our focus is on delivering innovative solutions through rigorous research and development, ultimately advancing patient care.
Tilde Sciences concentrates on two key products: Vecamyl®, a medication for hypertension, and Daraprim®, used in the treatment of toxoplasmosis.
Founded in 2023, Tilde Sciences operates from its headquarters in Jersey City, New Jersey, and is committed to providing accessible treatment options for patients with rare diseases. We prioritize patient access through comprehensive service and support programs, ensuring that individuals receive the medications they need.
Tilde Sciences concentrates on two key products: Vecamyl®, a medication for hypertension, and Daraprim®, used in the treatment of toxoplasmosis.
Founded in 2023, Tilde Sciences operates from its headquarters in Jersey City, New Jersey, and is committed to providing accessible treatment options for patients with rare diseases. We prioritize patient access through comprehensive service and support programs, ensuring that individuals receive the medications they need.
Contact Details
+11(833) 378-3537
info@tildesciences.com
Jersey City, United States (US), 101 Hudson st
Founded
2023
Company Type
Private Limited Company
Employees
10-20
Categories
Keywords
#rare diseases
Listings
Products
Companies teams usually look at after Tilde Sciences
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.